Skip to main content

Objective 3: GHP Trial Updates (October - November 2016)

Gynuity Health Projects, in collaboration with colleagues at Government Medical College, Nagpur and Daga Women’s Hospital are conducting a pragmatic, open-label, randomised control trial of three oral antihypertensive regimens for women with severe hypertension in pregnancy. Women presenting with severe hypertension will be randomised to one of three oral regimens: nifedipine, labetalol or methyldopa.

This trial will compare the efficacy, safety and side effects of these three oral regimens for management of severe hypertension in pregnant women. We hypothesize that nifedipine treatment of severe hypertensive parturient women is more effective than treatment with labetalol or methyldopa in controlling high blood pressure within six hours. The study will enroll 894 women at the two study sites in Nagpur, India: Government Medical College and Daga Women’s Hospital. Enrollment started in April 2015.

As of November 2016, 584 women were enrolled. In October 2016, the data and safety monitoring board conducted the planned interim analysis after half of the women were enrolled. The board concluded that enrollment should continue. We anticipate enrollment will be complete by August 2017.